semaglutide for research 5mg, 10mg, 20mg 3ML GLP-1SG – 10mg – Prime
Description
Do not change dose or schedule without prescriber direction
Regul Pept (1996) 63:1722
The highest risk appears to be in patients with type 2 diabetes who have established diabetic retinopathy at the time of treatment initiation, particularly when aggressive glycemic targets are pursued rapidly without appropriate ophthalmologic monitoring
Ongoing Support: Whether youre adjusting medication or re-focusing on lifestyle care, well be with you every step of the way
Adrian Soto-Mota and Dr
